Facebook
Twitter
Telegram
Report an ErrorBioCryst Pharmaceuticals Financial Ratios 2011-2024 | BCRX
Annual Financial Ratios BioCryst Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.0 | -6.8 | -16.2 | -9.9 | -3.0 | -8.9 | -5.9 | -8.1 | -11.8 | -15.0 | -19.0 | -2.0 | -2.8 |
P/S |
3.4 | 6.2 | 18.9 | 101.2 | 6.6 | 43.5 | 15.3 | 16.9 | 10.5 | 50.0 | 33.0 | 3.0 | 8.0 |
EPS |
-1.2 | -1.3 | -1.0 | -1.1 | -940 | -1.0 | -0.8 | -0.8 | -0.6 | -0.7 | -0.6 | -0.8 | -1.3 |
EV (Enterprise Value) |
1.01 B | 1.38 B | 2.47 B | 1.53 B | 347 M | 970 M | 429 M | 511 M | 556 M | 686 M | 601 M | 115 M | 209 M |
EBITDA per Share |
-0.53 | -0.79 | -0.99 | -1.04 | -0.854 | -0.906 | -0.671 | -0.653 | -0.539 | -0.683 | -0.551 | -0.637 | -1.08 |
EV/EBITDA |
-13.8 | -8.2 | -2.9 | -10.0 | -6.8 | -9.9 | -13.0 | -14.4 | -19.1 | -2.8 | -3.5 | ||
PEG |
0.59 | -1.31 | -1.65 | -0.66 | -0.73 | 0.35 | 1.46 | 0.3 | -0.89 | 0.64 | -0.63 | -0.05 | 0.04 |
P/B |
2.2 | 3.1 | 5.1 | 5.4 | 8.5 | 18.3 | 4.6 | 282.1 | 10.6 | 9.0 | -508.5 | -172.2 | 10.7 |
P/CF |
-11.8 | -10.4 | -20.9 | -13.3 | -3.6 | -9.7 | -9.3 | -7.6 | -27.9 | -17.6 | -21.6 | -2.1 | -4.9 |
ROE % |
49.73 | 83.88 | 172.04 | 949.09 | -284.68 | -205.65 | -78.53 | -3494.55 | -90.14 | -59.75 | 2673.89 | 8608.15 | -384.63 |
ROA % |
-43.82 | -44.93 | -31.30 | -54.62 | -62.13 | -68.95 | -36.90 | -61.38 | -34.54 | -33.02 | -61.61 | -68.04 | -69.27 |
ROCE % |
22.77 | 50.39 | 166.12 | 907.26 | -119.90 | -121.79 | -55.51 | -136.97 | -65.63 | -57.80 | -91.39 | -79.89 | -88.69 |
Current Ratio |
- | - | - | - | 1.8 | 1.6 | 1.7 | 1.2 | 1.0 | 1.5 | 2.8 | 2.4 | 2.0 |
DSO |
5.8 | 6.9 | 11.9 | 311.4 | 165.5 | 75.9 | 88.6 | 121.4 | 47.2 | 254.5 | 44.5 | 63.3 | 140.7 |
DIO |
2289.5 | 1233.9 | 576.4 | 828.8 | - | 1277.9 | - | 67.6 | 310.3 | 2043.4 | - | - | - |
DPO |
1435.6 | 1200.8 | 1174.4 | 3850.3 | 1245.0 | 6020.6 | 1359.0 | 577.3 | 1791.7 | 8523.6 | 15546.0 | 10988.7 | - |
Operating Cycle |
2295.4 | 1240.8 | 588.2 | 1140.2 | 165.5 | 1353.8 | 88.6 | 189.1 | 357.5 | 2297.9 | 44.5 | 63.3 | - |
Cash Conversion Cycle |
859.8 | 39.9 | -586.2 | -2710.1 | -1079.4 | -4666.8 | -1270.3 | -388.3 | -1434.1 | -6225.7 | -15501.5 | -10925.4 | - |
All numbers in USD currency
Quarterly Financial Ratios BioCryst Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.17 | - | -0.19 | -0.4 | -0.28 | - | -0.23 | -0.32 | -0.4 | - | -0.33 | -240 | -0.36 | -0.34 | -260 | -240 | -0.24 | -0.02 | -0.34 | -0.34 | -0.28 | -0.25 | -0.28 | -0.19 | -0.26 | -0.2 | -0.18 | -0.21 | -0.19 | -0.06 | -0.16 | -0.22 | -0.31 | -0.25 | -0.2 | 0.07 | -0.21 | -0.16 | -0.12 | -0.23 | -0.17 | -0.09 | -0.14 | -0.23 | -0.09 | -0.22 | -0.19 | -0.25 | -0.13 | -0.29 | -0.32 | -0.36 | -0.29 |
EBITDA per Share |
-0.07 | - | - | - | -0.15 | - | -0.09 | -0.19 | -0.27 | - | -0.25 | -0.17 | -0.29 | - | -0.24 | -0.22 | -0.23 | - | -0.22 | -0.22 | -0.19 | - | -0.25 | -0.16 | -0.2 | - | -0.13 | -0.15 | -0.11 | - | -0.12 | -0.16 | -0.26 | - | -0.18 | 0.07 | -0.2 | - | -0.16 | -0.18 | -0.12 | - | -0.11 | -0.2 | -0.09 | - | -0.15 | -0.19 | -0.09 | - | -0.27 | -0.3 | -0.25 |
ROE % |
44.40 | 44.42 | 61.94 | 70.67 | 78.89 | 90.31 | 130.30 | 152.76 | 165.88 | 166.44 | 480.49 | 679.91 | 839.62 | 949.09 | 628.18 | 290.50 | -8.30 | -284.68 | -333.55 | -295.38 | -234.48 | -205.65 | -173.26 | -131.22 | -113.91 | -78.53 | -340.56 | -1053.04 | -2064.63 | -3494.55 | -3247.19 | -2547.28 | -1505.26 | -90.14 | -67.57 | -48.48 | -78.12 | -59.75 | 437.84 | 1159.95 | 2260.31 | 2673.89 | 4626.32 | 6052.32 | 7675.29 | 8608.15 | 6084.47 | 3850.25 | 1036.39 | -384.63 | -97.66 | -109.89 | -87.98 |
ROA % |
-35.60 | -31.59 | -39.20 | -39.90 | -39.75 | -35.73 | -57.86 | -58.31 | -73.89 | -60.31 | -78.38 | -70.03 | -65.99 | -54.62 | -38.04 | -45.71 | -55.64 | -62.13 | -79.31 | -78.02 | -69.12 | -68.95 | -61.24 | -49.57 | -46.48 | -36.90 | -30.95 | -35.29 | -43.94 | -61.38 | -71.18 | -70.30 | -48.18 | -35.16 | -28.86 | -23.29 | -38.00 | -33.02 | -35.60 | -45.59 | -59.80 | -61.61 | -69.75 | -70.26 | -66.72 | -68.04 | -64.84 | -65.54 | -63.96 | -69.27 | -17.59 | -19.79 | -15.85 |
ROCE % |
14.17 | 16.88 | 24.07 | 28.36 | 39.32 | 53.89 | 84.21 | 107.35 | 118.95 | 126.72 | 349.25 | 541.46 | 713.50 | 635.20 | 543.44 | 229.16 | -62.05 | -259.71 | -317.59 | -283.70 | -229.49 | -140.06 | -155.99 | -114.06 | -95.51 | -47.21 | -632.83 | -1202.51 | -1952.68 | -2561.41 | -2588.99 | -2030.95 | -1251.06 | -46.62 | -61.97 | -49.74 | -76.30 | -40.48 | 574.53 | 1204.89 | 2298.58 | 2165.45 | 3931.09 | 5081.72 | 6244.80 | 5108.59 | 5022.11 | 3169.98 | 832.37 | -260.35 | -86.49 | -96.20 | -77.66 |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
2.9 | - | 2.0 | 1.8 | 6.2 | - | 1.8 | 1.4 | 3.6 | - | 10.9 | 13.7 | 40.1 | 187.3 | 123.3 | 262.0 | 287.5 | 50.9 | 1138.5 | 1395.6 | 204.9 | 143.6 | 269.4 | 31.4 | 119.5 | 143.5 | 63.7 | 180.1 | 72.0 | 89.1 | 103.1 | 167.1 | 142.1 | 123.8 | 51.9 | 22.0 | 67.5 | 64.5 | 108.5 | 239.6 | 78.7 | 19.4 | 85.6 | 235.1 | 85.7 | 101.5 | 72.3 | 98.9 | 38.8 | 101.8 | 101.4 | 142.5 | - |
DIO |
2108.6 | - | 2352.4 | 2781.3 | 2695.3 | - | 347.9 | 2994.2 | 6173.9 | - | 1814.9 | 2298.0 | 93.6 | - | 423.4 | - | - | - | - | - | 73.3 | - | - | - | - | - | 52.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1183.1 | - | 1015.3 | 1028.0 | 1010.0 | - | 111.0 | 2574.5 | 8059.6 | - | 2299.0 | 3627.9 | 248.4 | - | 1125.6 | - | - | - | - | - | 709.5 | - | - | - | - | - | 506.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
2111.5 | - | 2354.3 | 2783.1 | 2701.5 | - | 349.8 | 2995.5 | 6177.4 | - | 1825.8 | 2311.7 | 133.7 | 187.3 | 546.7 | 262.0 | 287.5 | 50.9 | 1138.5 | 1395.6 | 278.3 | 143.6 | 269.4 | 31.4 | 119.5 | 143.5 | 115.9 | 180.1 | 72.0 | 89.1 | 103.1 | 167.1 | 142.1 | 123.8 | 51.9 | 22.0 | 67.5 | 64.5 | 108.5 | 239.6 | 78.7 | 19.4 | 85.6 | 235.1 | 85.7 | 101.5 | 72.3 | 98.9 | 38.8 | 101.8 | 101.4 | 142.5 | - |
Cash Conversion Cycle |
928.4 | - | 1339.0 | 1755.1 | 1691.5 | - | 238.7 | 421.1 | -1882.1 | - | -473.2 | -1316.2 | -114.7 | 187.3 | -578.9 | 262.0 | 287.5 | 50.9 | 1138.5 | 1395.6 | -431.3 | 143.6 | 269.4 | 31.4 | 119.5 | 143.5 | -390.5 | 180.1 | 72.0 | 89.1 | 103.1 | 167.1 | 142.1 | 123.8 | 51.9 | 22.0 | 67.5 | 64.5 | 108.5 | 239.6 | 78.7 | 19.4 | 85.6 | 235.1 | 85.7 | 101.5 | 72.3 | 98.9 | 38.8 | 101.8 | 101.4 | 142.5 | - |
All numbers in USD currency